Rubicon Organics Inc (ROMJF)
0.30
+0.02
(+7.03%)
USD |
OTCM |
May 17, 13:26
Rubicon Organics Shareholders Equity (Quarterly): 27.18M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 27.18M |
| June 30, 2023 | 28.72M |
| March 31, 2023 | 27.82M |
| December 31, 2022 | 28.24M |
| September 30, 2022 | 29.74M |
| June 30, 2022 | 29.40M |
| March 31, 2022 | 30.50M |
| December 31, 2021 | 30.51M |
| September 30, 2021 | 31.14M |
| June 30, 2021 | 34.35M |
| March 31, 2021 | 36.65M |
| Date | Value |
|---|---|
| December 31, 2020 | 22.62M |
| September 30, 2020 | 18.45M |
| June 30, 2020 | 20.22M |
| March 31, 2020 | 11.12M |
| December 31, 2019 | 14.17M |
| September 30, 2019 | 16.81M |
| June 30, 2019 | 13.82M |
| March 31, 2019 | 15.34M |
| December 31, 2018 | 16.20M |
| September 30, 2018 | 19.19M |
| December 31, 2017 | 13.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.12M
Minimum
Mar 2020
36.65M
Maximum
Mar 2021
25.08M
Average
28.03M
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.00M |
| Total Liabilities (Quarterly) | 12.83M |
| Debt to Equity Ratio | 0.2872 |
| Current Ratio | 3.479 |
| Net Debt Paydown Yield | 7.59% |